Central nervous system targets mediating acetaminophen analgesia and antipyresis

The central nervous system (CNS) targets mediating acetaminophen (paracetamol) analgesia and antipyresis comprise a complex network of enzymes and receptors that differentiate its action from traditional NSAIDs (StatPearls, 2024; Frontiers in Pharmacology, 2020). Acetaminophen acts primarily as a prodrug; it is converted in the brain by fatty acid amide hydrolase (FAAH) into the bioactive metabolite N-arachidonoylphenolamine (AM404) (Frontiers in Pharmacology, 2020; Journal of Neuroscience, 2018). This metabolite serves as a potent activator of supraspinal transient receptor potential vanilloid 1 (TRPV1) channels and an inhibitor of endocannabinoid reuptake, which indirectly enhances signaling through cannabinoid CB1 receptors to modulate pain (Frontiers in Pharmacology, 2020; MDPI, 2023). Furthermore, acetaminophen inhibits cyclooxygenase (COX) enzymes within the CNS—including the proposed COX-3 splice variant—thereby reducing the synthesis of prostaglandin E2 (PGE2) in the hypothalamus to alleviate fever (StatPearls, 2024; MDPI, 2023). The drug also potentiates descending serotonergic inhibitory pathways, involving 5-HT1A, 5-HT3, and 5-HT7 receptors, to further suppress nociceptive transmission (StatPearls, 2024; Frontiers in Pharmacology, 2020). While highly effective for mild-to-moderate pain and fever, the therapeutic use of acetaminophen is limited by the risk of hepatotoxicity caused by the accumulation of its reactive metabolite, N-acetyl-p-benzoquinone imine (NAPQI), during overdose (StatPearls, 2024).

Other names

Acetaminophen CNS targetsParacetamol CNS targetsCyclooxygenase-3 (COX-3)AM404 targetsCNS cyclooxygenase

Acetaminophen acts as a prodrug that is converted in the CNS to the active metabolite AM404, which activates TRPV1 receptors and indirectly stimulates CB1 receptors by inhibiting anandamide reuptake. It also inhibits COX enzymes in the brain to reduce prostaglandin E2 synthesis, particularly in the hypothalamus for antipyresis, and modulates descending serotonergic inhibitory pathways.